Paulson & Co’s NuVasive, Inc. NUVA Stock Holding History

Paulson & Co’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-31,800	Closed	-$1.72M	–	103
2015 Q4	$1.72M	Buy	+31,800	New	+$1.62M	0.01%	68

Other funds holding NUVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Paulson & Co's NUVA Position: Q1 2016 in Review

Paulson & Co sold out of NuVasive, Inc. (NUVA) in Q1 2016, closing a stake of 31,800 shares — an estimated $1.72M sold.

Paulson & Co first reported a position in NUVA in Q4 2015 and held it in 1 quarter. The position peaked at $1.72M in Q4 2015. 249 funds tracked by Wall St. Rank hold NUVA as of Q1 2016.

Paulson & Co reported no remaining NuVasive, Inc. position as of Q1 2016 after selling out during the quarter.
Paulson & Co sold 31,800 NuVasive, Inc. shares in Q1 2016, an estimated $1.72M.
Paulson & Co first reported a position in NuVasive, Inc. in Q4 2015 and held it in 1 quarter.
Paulson & Co's NuVasive, Inc. position peaked at $1.72M in Q4 2015.
249 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2016.

Based on Paulson & Co's 13F filing for Q1 2016, filed 16 May 2016.